2015•China Foreign Medical TreatmentRequires access

Analysis of therapeutic effect of edaravone combined with ozagrel in treatment of acute cerebral infarction

Zhang Ku

Open publisher page 0 citations

Abstract

Objective To study the therapeutic effect of edaravone combined with ozagrel in treatment of acute cerebral infarction.Methods Selected 120 patients with acute cerebral infarction in our hospital and randomly divided into observation group and control group with 60 cases in each group.The observation group were treated by edaravone combined with ozagrel treatment,the control group patients were given edaravone treatment alone. Compared two groups of clinical therapeutic effect and the level of Creactive protein. Results The total effective rate of observation group was 91.67%,the control group the total effective rate was81.67%,the observation group was significantly higher than that in the control group,with significant difference(P 0.05); C reaction protein of the observation group after treatment was(7.06 ±1.43),which of the control group was(4.06 ±1.71),the decreased level of the observation group was significantly higher than the control group levels,with statistically significant difference(P 0.05). Conclusion The use of edaravone combined with ozagrel in treating acute cerebral infarction can not only improve the clinical treatment effect,but also can greatly reduce the level of C reactive protein,is worthy of clinical use.

About this research paper

What this paper is about

Objective To study the therapeutic effect of edaravone combined with ozagrel in treatment of acute cerebral infarction.Methods Selected 120 patients with acute cerebral infarction in our hospital and randomly divided into observation group and control group with 60 cases in each group.The observation group were treated by edaravone combined with ozagrel treatment,the control group patients were given edaravone treatment alone. Compared two groups of clinical therapeutic effect and the level of Creactive protein. Results The total effective rate of observation group was 91.67%,the control group the total effective rate was81.67%,the observation group was significantly higher than that in the control group,with significant difference(P 0.05); C reaction protein of the observation group after treatment was(7.06 ±1.43),which of the control group was(4.06 ±1.71),the decreased level of the observation group was significantly higher than the control group levels,with statistically significant difference(P 0.05). Conclusion The use of edaravone combined with ozagrel in treating acute cerebral infarction can not only improve the clinical treatment effect,but also can greatly reduce the level of C reactive protein,is worthy of clinical use.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the therapeutic effect of edaravone combined with ozagrel in treatment of acute cerebral infarction.Methods Selected 120 patients with acute cerebral infarction in our hospital and randomly divided into observation group and control group with 60 cases in each group.The observation group were treated by edaravone combined with ozagrel treatment,the control group patients were given edaravone treatment alone. Compared two groups of clinical therapeutic effect and the level of Creactive protein. Results The total effective rate of observation group was 91.67%,the control group the total effective rate was81.67%,the observation group was significantly higher than that in the control group,with significant difference(P 0.05); C reaction protein of the observation group after treatment was(7.06 ±1.43),which of the control group was(4.06 ±1.71),the decreased level of the observation group was significantly higher than the control group levels,with statistically significant difference(P 0.05). Conclusion The use of edaravone combined with ozagrel in treating acute cerebral infarction can not only improve the clinical treatment effect,but also can greatly reduce the level of C reactive protein,is worthy of clinical use.

Key concepts: Edaravone, Medicine, Therapeutic effect, Clinical efficacy, Significant difference, Anesthesia, Cerebral infarction, Conventional treatment

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of therapeutic effect of edaravone combined with ozagrel in treatment of acute cerebral infarction — Research Paper | ScholarLens